Deutschlands Chemie- und Pharmaindustrie am Scheideweg: Hohe Kosten, Fachkräftemangel und Bürokratie belasten – Report zeigt zentrale Hebel für eine zukunftsfähige Branche auf.
![Madjar-Navah.jpg](https://web-assets.bcg.com/dims4/default/275fc4e/2147483647/strip/true/crop/1047x1047+0+0/resize/500x500!/format/webp/quality/90/?url=http%3A%2F%2Fboston-consulting-group-brightspot.s3.amazonaws.com%2F76%2Fe2%2F699664f2459db9c5b5641331de5c%2Fmadjar-navah.jpg)
Education
- MSc, International Public Policy, University College London
- BA, European Studies, Maastricht University and University of Sydney
A core member of Boston Consulting Group's Industrial Goods practice, Madjar Navah specializes in engineered products and greentech, industrial distribution, and chemicals. He has comprehensive experience leading value-based and large-scale transformations, (digital) strategy development, and next generation sales engagements. He has led global transformation programs across all phases from strategy to design to implementation for both family and non-family businesses.
Madjar joined BCG in 2012. He is currently focusing on resilience-based initiatives that are based on differentiated business steering models, as well as the introduction of next generation sales models.